trending Market Intelligence /marketintelligence/en/news-insights/trending/jawksnndxmfcvuphcmaldw2 content esgSubNav
In This List

IMV gets Nasdaq listing approval

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


IMV gets Nasdaq listing approval

Canada's IMV Inc. said its common stock was approved for listing on the Nasdaq under the IMV symbol starting June 1.

The cancer therapy developer will retain its listing on the Toronto Stock Exchange but will no longer trade on the OTCQX once it moves to Nasdaq.